Associate Director, Global Strategic Marketing at Tarsus Pharamceuticals

Irvine, California, United States

Tarsus Pharamceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Bachelor’s degree in Marketing, Business, or related field with 12+ years of related experience; or MBA or advanced degree (preferred) with 10+ years of related experience
  • Minimum of 5–7 years of experience in global pharmaceutical/biotech marketing; pipeline and launch planning experience strongly preferred
  • Proven success in brand management, product launch, and lifecycle management
  • Strong analytical skills with data-driven decision-making experience
  • Excellent communication and influencing skills across geographies and functions
  • Ability to thrive in a fast-paced, matrixed environment with multiple priorities
  • Willingness to travel globally (up to ~30%)

Responsibilities

  • Define and lead global brand strategies and launch plans to drive Tarsus’ growth across key therapeutic areas
  • Lead commercial planning — including value proposition, messaging, and global evidence generation — to enable launch excellence
  • Partner with regional teams to translate global strategy into regional execution, ensuring brand consistency while tailoring to local dynamics
  • Oversee the development of integrated, multi-channel global campaigns to drive awareness and engagement among HCPs, payers, and patients
  • Represent Tarsus’ global commercial function at international congresses, advisory boards, and customer meetings, fostering strategic partnerships with key stakeholders
  • Serve as the commercial voice on development-stage Core Teams, embedding early commercial thinking into clinical and regulatory strategy
  • Lead market shaping and pre-commercial planning for pipeline assets, including early positioning, segmentation, and value narrative development
  • Partner closely with R&D and Market Access to ensure target product profiles (TPPs) and development plans align with unmet market needs and commercial viability
  • Build early advocacy among KOLs, payers, and patient organizations to prepare the market for successful entry and lifecycle expansion
  • Generate market insights and competitive intelligence to inform strategy and measure performance
  • Build forecasts and conduct scenario planning for pipeline assets and lifecycle management opportunities to inform resource allocation and prioritization
  • Measure campaign effectiveness and report ROI to stakeholders, continuously optimizing for impact
  • Collaborate cross-functionally with Medical, Clinical, Regulatory, Market Access, and regional teams to ensure aligned execution
  • Manage budgets, vendors, and agencies effectively while maintaining compliance with all regulations

Skills

Global Brand Strategy
Launch Planning
Commercial Planning
Value Proposition
Messaging
Evidence Generation
Multi-Channel Campaigns
Market Insights
Cross-Functional Leadership
Stakeholder Engagement
HCP Engagement
Payer Strategy
Patient Engagement

Tarsus Pharamceuticals

Develops treatments for eye care diseases

About Tarsus Pharamceuticals

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company is also working on other potential treatments for conditions such as Lyme Disease Prevention, Meibomian Gland Disease, and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong pipeline of future products. Their goal is to provide effective treatments for patients suffering from these conditions while ensuring compliance with regulations and ethical standards.

Irvine, CaliforniaHeadquarters
2017Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in ophthalmic treatments challenges Tarsus's market position.
Potential clinical trial delays could affect Tarsus's product pipeline.
Supply chain constraints may hinder XDEMVY's production and distribution.

Differentiation

Tarsus focuses on high unmet needs in ophthalmic and infectious diseases.
Their lead product, XDEMVY, is FDA-approved for Demodex blepharitis treatment.
Tarsus's pipeline includes innovative treatments for Lyme disease and Rosacea.

Upsides

Growing awareness of Demodex blepharitis expands market for Tarsus's XDEMVY.
Telemedicine rise offers new marketing opportunities for Tarsus's products.
FDA's focus on unmet needs may expedite Tarsus's pipeline approvals.

Land your dream remote job 3x faster with AI